CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-27 | Jacobson Mark L. CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +32,825 | 32,825 | ||
| 2024-02-27 | Jacobson Mark L. CHIEF OPERATING OFFICER | Grant or award · Restricted Stock Units | +18,027 | 18,027 | ||
| 2024-02-27 | Pizzie Nick CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +28,722 | 28,722 | ||
| 2024-02-27 | Pizzie Nick CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +15,774 | 15,774 | ||
| 2024-02-27 | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +87,192 | 87,192 | ||
| 2024-02-27 | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +47,886 | 47,886 | ||
| 2024-02-27 | Mahony Susan Director | Grant or award · Stock Option (Right to Buy) | +191 | 191 | ||
| 2024-02-27 | Murdock Hunter R. General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +23,593 | 23,593 | ||
| 2024-02-27 | Murdock Hunter R. General Counsel | Grant or award · Restricted Stock Units | +12,956 | 12,956 | ||
| 2023-10-10 | Mahony Susan Director | Grant or award · Stock Option (Right to Buy) | +1,502 | 1,502 | ||
| 2023-10-10 | Mahony Susan Director | Grant or award · Stock Option (Right to Buy) | +5,873 | 5,873 | ||
| 2023-09-15 | Coleman Mark Director | Option exercise 10b5-1 | +11,016 | $3.67 | $40K | 36,113 |
| 2023-09-15 | Coleman Mark Director | Sale 10b5-1 | −11,016 | $75.19 | $828K | 25,097 |
| 2023-09-15 | Coleman Mark Director | Sale 10b5-1 | −18,572 | $75.18 | $1.4M | 403,856 |
| 2023-09-15 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,016 | 0 | ||
| 2023-06-02 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +5,681 | 5,681 | ||
| 2023-06-02 | JEFFS ROGER Director | Grant or award · Stock Option (Right to Buy) | +5,681 | 5,681 | ||
| 2023-06-02 | Coleman Mark Director | Grant or award · Stock Option (Right to Buy) | +5,681 | 5,681 | ||
| 2023-03-02 | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +110,032 | 110,032 | ||
| 2023-03-02 | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +62,400 | 62,400 |
Page 13 of 22 · 422 trades